Full Press Release Details
IDEAYA Biosciences, Inc Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update.
IDYA
IDEAYA Biosciences, Inc Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Key Takeaway: IDEAYA Biosciences, Inc Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Price reaction · baseline $47.13 (2024-02-16 close) · hit after-hours · clean, no other IDYA news in the window
day 0 close · peak
-6.6%
day 1
-6%
day 3
-2.7%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma